Search result · source text not verified
Biologics CDMO drug substance & sterile drug product manufacturing, from first clinical batch to commercial supply.
Products
Process & Analytical DevelopmentAccelerate your biologics with Resilience. CDMO providing process & analytical development.
Drug Substance ManufacturingBiologics drug substance manufacturing for complex molecule production, from clinical development to commercial supply, including tech transfer & purification.
Drug Product ManufacturingSterile drug product manufacturing CDMO solutions for clinical and commercial supply. Formulation, aseptic filling, testing, & packaging services.
Fill/FinishAseptic fill/finish CDMO services for biotech & pharma. From clinical vials to commercial prefilled syringes and cartridges, ensure your product's integrity.
Device Assembly, Packing & LogisticsDrug delivery, device assembly, drug product packaging, serialization & and finished-goods logistics. Streamline sterile drug product delivery with Resilience.
No matching products or features.
Customer feedback
Search result · source text not verified
Apparently "Resilience" is coming back meaning stockpile food
Sources now rumbling that due to Russia we'll see, before the end of the weekend, the government using the phrase resilience to tell us gently to stockpile food.
Search result · source text not verified
Resilience is a word for people who had options
Search result · source text not verified
Resilience layoff? : r/biotech
I’m seeing a lot of posts on LinkedIn about Resilience (a CDMO) laying off people. But no news article about it. Does anyone know what happened and why? ...
Search result · source text not verified
Do any of you get “Resilience” ratings other than “low” ...
My other metrics don’t seem that bad, but I noticed that this new metric that is tracked is consistently “low”? HRV goes into “Resilience” rating, ...
Search result · source text not verified
resilience is one of the most pointless therapy concepts
I think resilience is supposed to be an empowering concept, ie: “You're really strong to have survived that!” For me, that hasn't been helpful ...
Search result · source text not verified
Life Sciences Resilience Report 2026 Outlook
Explore life sciences bankruptcy trends, resilience signals, and what 2025 and 2026 may mean for the industry's outlook.
Search result · source text not verified
20 months, 2K hours, 200K € lost. A story about resilience ...
A story about resilience and sunk cost fallacy … costs a bit more can actually save time and money. two more years of development time. . The ...
No feedback found.
Marketing & Ads
GoogleWBNS TV Inc.
Original ad ↗
First shown Jan 22, 2026 · Last shown Oct 22, 2026Landing page unavailable: the ad source did not supply a destination URL.
GoogleWBNS TV Inc.
Original ad ↗
First shown Jan 22, 2026 · Last shown Oct 22, 2026Landing page unavailable: the ad source did not supply a destination URL.
GoogleWBNS TV Inc.
Original ad ↗
First shown Jan 22, 2026 · Last shown Oct 22, 2026Landing page unavailable: the ad source did not supply a destination URL.
GoogleWBNS TV Inc.
Original ad ↗
First shown Jan 22, 2026 · Last shown Oct 22, 2026Landing page unavailable: the ad source did not supply a destination URL.
Website marketing
Contact Resilience | Biologics Manufacturing CDMO ↗
Explore Resilience’s services, including cell line development, viral vector manufacturing, biologics manufacturing, and analytical & process development.
Observed Nov 11, 2026
Contact Resilience | Biologics Manufacturing CDMO ↗
Explore Resilience’s services, including cell line development, viral vector manufacturing, biologics manufacturing, and analytical & process development.
Observed Nov 11, 2026
New pages
The People Behind the Process: How Resilience’s Teams Enable Flexible Biopharma Manufacturing ↗
Resilience Further Advances North American Manufacturing Strategy Transformation ↗
The Future of CDMOs: Navigating the Combinations Interview with Kothari and Jonathon Amaya-Hodges ↗
On Demand Webinar: Outsourced Pharma Capabilities Update - Large Molecule ↗
Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply ↗
Resilience Announces Relocation of West Coast Headquarters to Ohio and Expansion of Sterile Manufacturing Capabilities ↗
From Complexity to Clarity - Sharpening Focus for Long-Term Performance in a More Demanding CDMO Era ↗
Redefining CAR-T Speed and Strength with DAR-T™: A Conversation with Nicholas Kirian ↗
Modified Source ↗
Process & Analytical Development for Programs with GMP in Sight ↗
Modified Source ↗
Device Assembly, Packaging & Logistics for Late-Stage and Commercial Sterile Drug Products ↗
Modified Source ↗
Biologics & Sterile Drug Product Manufacturing for Biotech ↗
Modified Source ↗
Reliable Commercial Supply for Pharma ↗
Modified Source ↗
drug substance manufacturing ↗
Modified Source ↗
cdmo fill finish ↗
Modified Source ↗
drug product manufacturing ↗
Modified Source ↗
cookie preferences ↗
Modified Source ↗
our team ↗
Modified Source ↗
facilities overview ↗
Modified Source ↗
Insights on Biologics Manufacturing & Development ↗
Modified Source ↗
blog old ↗
Modified Source ↗
accelerating clinical timelines of induced pluripotent stem cells ipscs with pluristyx ↗
Modified Source ↗
executive interview advancing therapies that transform lives ↗
Modified Source ↗
meet the team viral vector development manufacturing ↗
Modified Source ↗
finish trends challenges and whats ahead ↗
Modified Source ↗
finish services outsourced pharma capacity update ↗
Modified Source ↗
finish ↗
Modified Source ↗
resilience announces appointment of william s. marth rph. mba as chief executive officer ↗
Modified Source ↗
resilience announces equity investment from mubadala and funding of new biopharma manufacturing facility in the united arab emirates ↗
Modified Source ↗
resilience is proud to support cargo therapeutics novel allogeneic car t cell therapy ↗
Modified Source ↗
careers ↗
Let’s Connect ↗
Modified Source ↗
corporate compliance ↗
Modified Source ↗
events ↗
Modified Source ↗
events old ↗
Modified Source ↗
facilities blue ash ↗
Modified Source ↗
facilities request a tour ↗
Modified Source ↗
facilities toronto ↗
Modified Source ↗
facilities west chester ↗
Modified Source ↗
privacy policy ↗
Modified Source ↗
safety inquiries ↗
Modified Source ↗
terms of service ↗
Modified Source ↗
resilience to present at the 42nd annual j.p. morgan healthcare conference ↗
Modified Source ↗
developing new medicines through artificial intelligence ↗
Modified Source ↗
how digital twins help improve biomanufacturing quality and security ↗
How Integrated Data Systems Enhance Clinical Development and Manufacturing ↗
Modified Source ↗
on demand presentation improving cell line development in cho with a focus on product manufacturability ↗
Modified Source ↗
on demand video efficiency meets economy the power of single use chromatography in mab purification ↗
Modified Source ↗
on demand webinar optimize research and delivery of complex medicines using data insights ↗
Modified Source ↗
on demand webinar outsourced pharma capacity update drug substance ↗
Modified Source ↗
resilience announces joint venture with lifera in saudi arabia ↗
Modified Source ↗
resilience appoints bill marth as president of services ↗
Modified Source ↗
resilience appoints dr. susan billings chief commercial officer ↗
Modified Source ↗
resilience builds lab supply chain tracking platform on aws ↗
Modified Source ↗
starburst data rebel awards data product of the year ↗
Modified Source ↗
bluebird bio and resilience announce strategic alliance to develop next generation cell therapies ↗
Modified Source ↗
boston ma process analytical development and manufacturing facility ↗
Modified Source ↗
bridgebio and resilience announce strategic multi year partnership ↗
Modified Source ↗
finish timelines your guide to quality and regulatory success in the cdmo space ↗
Modified Source ↗
cdmos are making their supply chains more resilient secure ↗
Modified Source ↗
fireside chat with rahul signhvi ceo of resilience ↗
Modified Source ↗
how an east bay site may lead a biotech manufacturing revolution ↗
Modified Source ↗
how resilience is bringing forward thinking to disrupt the biomanufacturing landscape to increase access to medicines ↗
Modified Source ↗
meet the 24 biotech startups that top vcs say are poised to take off in the next 12 months ↗
Modified Source ↗
national resilience honored by goldman sachs for entrepreneurship ↗
Modified Source ↗
finish solutions presentation ↗
Modified Source ↗
on demand video idea to clinic aim to reduce your manufacturing timeline by 30 ↗
Modified Source ↗
on demand webinar establishing a stage gate approach to biomanufacturing ↗
Modified Source ↗
on demand webinar future proof your aseptic filling ↗
Modified Source ↗
problem solving for aseptic filling ↗
Modified Source ↗
raging at the pandemic a vc raises 800m for a company that aims to transform biotech manufacturing ↗
Modified Source ↗
resilience acquires swiftscale biologics a leader in cell free protein synthesis technology ↗
Modified Source ↗
resilience and harvard university announce five year rd alliance to incubate new technologies launch companies to advance the manufacture of complex medicines ↗
Modified Source ↗
resilience and jobsohio announce continued partnership and expansion in blue ash ↗
Modified Source ↗
resilience and md anderson launch joint venture to accelerate development and manufacturing of innovative cell therapies for cancer ↗
Modified Source ↗
resilience and taiwan bio manufacturing corporation announce groundbreaking partnership in biomanufacturing innovation ↗
Modified Source ↗
resilience announces 625 million series d financing to expand network bring innovative technologies to biomanufacturing ↗
Modified Source ↗
resilience announces collaboration to manufacture and deliver biotherapeutics for rare and complex conditions ↗
Modified Source ↗
resilience announces expansion in west chester ↗
Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy ↗
Modified Source ↗
resilience approved for 410m financing from the department of defense to establish resilient biomanufacturing capacity ↗
Modified Source ↗
resilience bags sanofi genzyme plant in boston ↗
Modified Source ↗
resilience becomes biomanufacturing resource partner for california institute for regenerative medicine ↗
Modified Source ↗
resilience continues expansion with acquisition of biologics manufacturing company ology bioservices ↗
Modified Source ↗
resilience establishes multi product development and manufacturing collaboration with takedas plasma derived therapies business unit ↗
Modified Source ↗
resilience expands clinical and commercial drug product manufacturing capabilities and capacities ↗
Modified Source ↗
resilience expands north american capacity with the acquisition of two premier biologics manufacturing facilities ↗
Modified Source ↗
resilience joins forces with childrens hospital of philadelphia to develop next generation biomanufacturing technologies create impactful therapies ↗
Modified Source ↗
resilience launches to change the future of medicine through manufacturing innovation ↗
Modified Source ↗
resilience partners with parvus therapeutics for development and manufacturing of pvt401 a novel autoimmune drug candidate for ibd ↗
Modified Source ↗
resilience receives usd 164 million investment from the government of canada to modernize and expand its ontario biomanufacturing site ↗
Modified Source ↗
resilience signs multi year strategic biomanufacturing partnership with leading pharmaceutical company ↗
Modified Source ↗
resilience subsidiary ology bioservices awarded contract worth up to 250 million from u.s. department of defense for botulinum neurotoxin treatment ↗
Modified Source ↗
resilience to establish a biomanufacturing partnership with astrazeneca and purchase astrazenecas manufacturing site in west chester ohio ↗
Modified Source ↗
resilience to manufacture mrna for modernas covid 19 vaccine ↗
Modified Source ↗
revised annex 1 and the focus on microbial control strategies ↗
Modified Source ↗
sanofi prepares to transfer allston plant to a new company but not its city tax breaks ↗
Modified Source ↗
the stage gate model a proven approach to streamline biomanufacturing ↗
Modified Source ↗
with stars aligned and cash in reserve bob nelsens resilience plans a makeover at 2 new facility additions to its drug manufacturing upstart ↗
Modified Source ↗
american biomanufacturing summit 2025 ↗
Modified Source ↗
asgct 2025 ↗
Modified Source ↗
atw 2025 ↗
Modified Source ↗
bio international convention 2025 ↗
Modified Source ↗
biomanufacturing world summit bmws 2025 ↗
Modified Source ↗
bioprocess international 2025 ↗
Modified Source ↗
bioprocess international 2026 ↗
Modified Source ↗
biotech showcase 2025 ↗
Modified Source ↗
car tcr summit 2025 ↗
Modified Source ↗
contract pharma 2025 ↗
Modified Source ↗
cphi worldwide 2025 ↗
Modified Source ↗
dcat week 2025 ↗
Modified Source ↗
jp morgan 2025 ↗
Modified Source ↗
advanced therapies week ↗
Modified Source ↗
american biomanufacturing summit ↗
Modified Source ↗
biomanufacturing world summit ↗
Modified Source ↗
biotech showcase ↗
Modified Source ↗
cdmo live americas ↗
Modified Source ↗
contract pharma 2026 ↗
Modified Source ↗
cphi worldwide ↗
Modified Source ↗
dcat week ↗
Modified Source ↗
jp morgan healthcare conference ↗
Modified Source ↗
massbio rd reimagined advanced modalities ↗
Modified Source ↗
offline ↗
Modified Source ↗
knowledge ↗
Modified Source ↗
kb 404 ↗
Modified Source ↗
kb search results ↗
Modified Source ↗
news ↗
Modified Source ↗
blog 25 test ↗
Modified Source ↗
events 25 test ↗
Modified Source ↗
news 25 test ↗
Modified Source ↗
offerings test ↗
Brand colors & fonts
Observed website styles · partial · Nov 11, 2026
Font previews use system fonts. Font reuse rights are unverified. These styles are not verified official brand guidelines.
CSS declarations only; browser rendering, cascade, active theme, loaded fonts and official brand guidelines have not been verified. Generated font aliases are normalized for display; exact declarations remain in cssFamily. Colors are semantic declaration samples, not an exhaustive palette. Font asset URLs are evidence only; license and redistribution rights are unknown.